Tas, F. And Erturk, K. 2021. Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1 , 40-45.

Tas, F., & Erturk, K., (2021). Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1, 40-45.

Tas, Faruk, And K Erturk. "Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1, 40-45, 2021

Tas, Faruk And Erturk, K. "Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1, pp.40-45, 2021

Tas, F. And Erturk, K. (2021) . "Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1, pp.40-45.

@article{article, author={Faruk TAŞ And author={K Erturk}, title={Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year=2021, pages={40-45} }